Stock 4570 IMMUNO-BIOLOGICAL LABORATORIES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Immuno-Biological Laboratories Co., Ltd.

Equities

4570

JP3921300004

Delayed Japan Exchange
Other stock markets
 09:36:39 2024-05-23 pm EDT 		5-day change 1st Jan Change
501 JPY +0.40% Intraday chart for Immuno-Biological Laboratories Co., Ltd. -0.40% +1.62%
2023 Immuno-Biological Laboratories Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
2023 An unknown buyer agreed to acquire unknown minority stake in CURED Co., Ltd. from Immuno-Biological Laboratories Co., Ltd. CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Immuno-Biological Laboratories Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023
CI
An unknown buyer agreed to acquire unknown minority stake in CURED Co., Ltd. from Immuno-Biological Laboratories Co., Ltd.
CI
An undisclosed buyer acquired 26.32% stake in Cell Remover Co., Ltd. from Immuno-Biological Laboratories Co., Ltd..
CI
Transgenic Inc. Enters into Joint Research Agreement with Immuno-Biological Laboratories Co. Ltd
CI
Hideki Egawa cancelled the acquisition of 79.6 % stake in M Cosmetics Co., Ltd. from Immuno-Biological Laboratories Co., Ltd., Mitsuru Onishi and others.
CI
Hideki Egawa signed a contract to acquire 79.6 % stake in M Cosmetics Co., Ltd. from Immuno-Biological Laboratories Co., Ltd., Mitsuru Onishi and others for ¥20.6 million.
CI
Xseed High Growth I managed by Japan Asia Investment Co. Ltd. acquired Skylight Biotech Inc.
CI
Astellas Pharma and Immuno-Biological Conclude Collaborative Research Agreement
CI
Immuno-Biological Laboratories Co., Ltd. completed the acquisition of 41.7% stake in Skylight Biotech Inc.
CI
Immuno-Biological Laboratories Co., Ltd. completed the acquisition of 58.3% stake in Skylight Biotech Inc. from a group of sellers.
CI
Immuno-Biological Laboratories Co., Ltd. agreed to acquire 41.7% stake in Skylight Biotech Inc. for approximately ¥150 million.
CI
Immuno-Biological Laboratories Co., Ltd. agreed to acquire 58.3% stake in Skylight Biotech Inc. from a group of sellers for approximately ¥160 million.
CI
Immuno-Biological Laboratories Co., Ltd. Signs Collaboration and License Agreement with IBL International GmbH
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4570 Stock
  4. News Immuno-Biological Laboratories Co., Ltd.
  5. Highlights